Alinsa, Ellaine S.
HRN: 09-26-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/22/2024
08/29/2024
IV
2.25
Q6
CAP
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes